Dr. Michael O’Reilly Appointed as Chief Medical Advisor for C10 Labs to Drive AI in Healthcare
C10 Labs has announced the appointment of Dr. Michael O’Reilly as Chief Medical Advisor, a strategic move aimed at enhancing the company’s initiatives in AI-driven healthcare solutions. O’Reilly, who previously held the position of Vice President of Medical Technology at Apple, brings extensive expertise to C10 Labs as it seeks to bridge the gap between cutting-edge AI research and practical healthcare applications.
This appointment comes at a pivotal time, as C10 Labs expands its focus on developing ventures that integrate digital intelligence with real-world healthcare systems. The studio is notably leading NYC’s AI Nexus program, an initiative designed to support over 100 AI ventures through the year 2029.
According to Shahid Azim, Founder and CEO of C10 Labs, “Michael possesses a unique blend of in-depth clinical knowledge and experience in large-scale execution.” His previous accomplishments include successfully implementing medical sensors into consumer devices at Apple, benefitting over a billion users, and developing vital monitoring technology at Masimo Corporation, a standard in hospitals globally.
In addition to his corporate roles, Dr. O’Reilly serves as an Adjunct Associate Professor at the University of Michigan, where he is involved in advancing clinical innovation and education in translational research.
Dr. O’Reilly expressed his enthusiasm for C10 Labs, stating, “They don’t merely invest; they actively collaborate with founders to tackle fundamental challenges in healthcare AI. By integrating access to MIT and Harvard research with hands-on development support, C10 Labs is uniquely positioned to make a significant impact on healthcare delivery.”
C10 Labs operates from both MIT’s Kendall Square and New York City, employing their Applied Venture Science methodology to significantly reduce development timelines from the typical 18-24 months to just 90-120 days. The organization actively seeks collaborations with principal investigators, investors, and technical founders aiming to innovate at the intersection of healthcare and AI.
Shahid Azim emphasized the studio’s foundational role, remarking, “We are creating the infrastructure that will fundamentally transform healthcare this decade. Dr. O’Reilly’s insights will be instrumental in discerning which technologies can effectively scale to benefit millions.”
For those interested in collaborating with C10 Labs to build startups in this evolving landscape, further information is available at their website.
C10 Labs is focused on leveraging AI to develop commercially viable ventures in various sectors, including healthcare, energy, and industrial systems.
